A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. J Am Coll Cardiol. 2011;58:645 651. doi: 574. Lanz J, Brophy JM, Therrien J, Kaouache M, Guo L, Marelli AJ. Stroke in adults with congenital heart disease: incidence, cumulative risk, and predictors. Circulation. 2015;132:2385 2394. doi: 10.1161/ 575. Mandalenakis Z, Rosengren A, Lappas G, Eriksson P, Hansson PO, Dellborg M. Ischemic stroke in children and young adults with congeni- tal heart disease. J Am Heart Assoc. 2016;5:e003071. doi: 10.1161/ 576. Hoffmann A, Chockalingam P, Balint OH, Dadashev A, Dimopoulos K, Engel R, Schmid M, Schwerzmann M, Gatzoulis MA, Mulder B, et al. Cerebrovascular accidents in adult patients with congenital heart disease. 577. Nattel SN, Adrianzen L, Kessler EC, Andelfinger G, Dehaes M, C t -Corriveau G, Trelles MP. Congenital heart disease and neurodevelop- ment: clinical manifestations, genetics, mechanisms, and implications. Can J Cardiol. 2017;33:1543 1555. doi: 10.1016/j.cjca.2017.09.020 578. Hebson CL, McCabe NM, Elder RW, Mahle WT, McConnell M, Kogon BE, Veledar E, Jokhadar M, Vincent RN, Sahu A, et al. Hemodynamic phenotype of the failing Fontan in an adult population. Am J Cardiol. 2013;112:1943 579. Triedman JK. Arrhythmias in adults with congenital heart disease. Heart. 580. de Groot NM, Atary JZ, Blom NA, Schalij MJ. Long-term outcome af- ter ablative therapy of postoperative atrial tachyarrhythmia in patients with congenital heart disease and characteristics of atrial tachyarrhyth- mia recurrences. Circ Arrhythm Electrophysiol. 2010;3:148 154. doi: 581. McRae ME. Long-term issues after the Fontan procedure. AACN Adv Crit 582. Georgekutty J, Kazerouninia A, Wang Y, Ermis PR, Parekh DR, Franklin WJ, Lam WW. Novel oral anticoagulant use in adult Fontan patients: a single center experience. Congenit Heart Dis. 2018;13:541 547. doi: 583. 